corporations

Netherlands: Long-term research to optimize cannabis cultivation approved

Published

2 years ago

December 21, 2023

The Medical Cannabis Platform for Innovation and Research (MCPIR) has received a license to carry out long-term research into the cultivation of medicinal cannabis in the Netherlands. The project was initiated by Delphy, who in collaboration with other companies in the horticulture industry established the MCPIR platform. An ambitious five-year program is now focused on researching the most effective methods for growing medicinal cannabis.

MCPIR's objective is to develop a professionalized cultivation model, through advanced research in its state-of-the-art, fully operational facilities.

With official approval for long-term research, MCPIR begins the phenotyping process, a crucial stage in selecting the ideal cannabis genetics. This phase will last several months and aims to optimize the yield and production of specific active compounds. In addition, MCPIR will explore other topics such as the optimal temperature/lighting ratio (RTR – Radiation Temperature Ratio) in combination with the correct nutrients, biostimulants and climate settings to enhance understanding of ideal growing conditions for medical cannabis.

Collaboration between licensed cannabis producers

The differentiating factor of this project is offering licensed producers access to reliable information through a unique platform, developed in a market-oriented research facility, consolidating itself as a central point for the community. In addition to Delphy, MCPIR founding partners include Philips Horticulture LED Solutions by Signify, Koppert B.V., Paradise Seeds, Priva, Mills Nutrients & Substrates Brightlabs, Can-Filters, Cannabis Drying, Cannavigia, DLVge and Van Vliet Newwen. The companies contribute their technical expertise and the collaboration covers cultivation consultancy, lighting strategies, climate control, fertilization, substrate and natural pest and disease control methods.

MCPIR has two levels of participation: founding partner or member, which provides participants with access to facilities equipped with cutting-edge technology, specialized knowledge and advancement opportunities; organization of events and training actions to share knowledge with interested parties, actively participating in international events relevant to the industry.

By bringing together industry-leading companies, MCPIR continues to play a crucial role in promoting innovation and collaboration in the medical cannabis industry. This advancement represents a significant step forward for the cannabis research and production community, promising to contribute to the improvement of cultivation practices and the expansion of knowledge in the field of medicine.

____________________________________________________________________________________________________

[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

Antonio João Costa

I am one of the directors of CannaReporter, which I founded together with Laura Ramos. I am from the unique Island of Madeira, where I currently reside. While I was in Lisbon at FCUL studying Physical Engineering, I became involved in the national hemp and cannabis scene and participated in several associations, some of which I am still a member of. I follow the global industry and especially legislative advances regarding the different uses of cannabis.

I can be contacted by email at joao.costa@cannareporter.eu